Page last updated: 2024-08-22

streptomycin and Buruli Ulcer Disease

streptomycin has been researched along with Buruli Ulcer Disease in 52 studies

Research

Studies (52)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	7 (13.46)	29.6817
2010's	40 (76.92)	24.3611
2020's	5 (9.62)	2.80

Authors

Authors	Studies
Almeida, DV; Converse, PJ; Grosset, JH; Li, SY; Nuermberger, EL; Zhang, T	1
Aroso, I; Correlo, VM; Fraga, AG; Marques, AP; Mendes, AI; Pedrosa, J; Rebelo, R	1
Akiyama, M; Constance, K; Kouadio, K; Murase, C; N'Golo, DC; N'guessan, K; N'Guetta, A; Vagamon, B; Yao, A; Yotsu, RR	1
Johnson, PDR	1
Abass, KM; Agossadou, D; Ampadu, EO; Asiedu, KB; Chauty, A; Egondi, TW; Frimpong, M; Ganlonon, L; Gateau, T; Grosset, J; Lehman, L; Macdonald, JM; Marion, E; Ochieng Otieno, M; Ohene, SA; Omollo, R; Paintsil, A; Phillips, RO; Robert, J; Saizonou, R; Sarfo, FS; Sarpong, G; Sarpong, NF; Saunderson, P; Stienstra, Y; Thompson, W; Tiendrebeogo, A; Treadwell, T; van der Werf, TS; Wansbrough-Jones, M; Wilson, T	1
Abbass, A; Dzudzor, B; Gyamfi, E; Mosi, L; Narh, CA; Quaye, C	1
Guarner, J	1
Agbo, IE; Amoussouhoui, AS; Aoulou, P; Boyer, M; Houezo, JG; Johnson, RC; Nichter, M; Sopoh, GE; Wadagni, AC	1
Ishii, N; Richardson, M; Yotsu, RR	1
Almeida, DV; Converse, PJ; Nuermberger, EL; Tyagi, S; Xu, J	1
Almeida, DV; Converse, PJ; Grosset, JH; Li, SY; Nuermberger, EL; Tyagi, S	1
Almeida, DV; Converse, PJ; Grosset, JH; Robinson, C; Sarfo, FS; Wansbrough-Jones, M; Zhang, J	1
Anku, B; Asan-Ampah, K; Kpeli, GS; Kwakye-Maclean, C; Lamptey, I; Newman, M; Owusu-Mireku, E; Paintsil, A; Pluschke, G; Quenin-Fosu, K; Ruf, MT; Yeboah-Manu, D	1
Abass, MK; Abotsi, J; Amoako, YA; Asiedu, K; Forson, M; Phillips, RO; Sarfo, FS; Thompson, W; Wansbrough-Jones, M; Wilson, T	1
Abass, KM; Klis, S; Phillips, RO; Stienstra, Y; Tuah, W; van der Werf, TS	1
Athan, E; Buntine, J; Callan, PP; Friedman, ND; Horne, S; Hughes, A; Jenkin, G; Johnson, PD; McDonald, A; O'Brien, DP; Steffen, CM	1
Asiedu, KB; Babonneau, J; Kempf, M; Marion, E; Marsollier, L; Obvala, D	1
Kingma, R; Klis, S; Stienstra, Y; Tuah, W; van der Werf, TS	1
Abass, MK; Amoako, YA; Ampadu, E; Asiedu, K; Forson, M; Frimpong, M; Phillips, RO; Sarfo, FS; Thompson, W; Wansbrough-Jones, M	1
Johnson, PD; Omansen, TF; Porter, JL; Stienstra, Y; Stinear, TP; van der Werf, TS	1
Adamson, J; Converse, PJ; Grosset, JH; Kishi, Y; Li, SY; Nuermberger, EL; Tyagi, S; Xing, Y	1
Aboagye, S; Akuoku, V; Ampofo, W; Bonney, K; Kpeli, G; Owusu-Mireku, E; Paintsil, A; Pereko, J; Pluschke, G; Ruf, MT; Tuffour, J; Yeboah-Manu, D	1
Adu, EJ; Ampadu, E	1
Kingma, RA; Klis, S; Stienstra, Y; Tuah, W; van der Werf, TS	1
Abass, KM; Agumah, E; de Zeeuw, J; Klis, S; Phillips, RO; Stienstra, Y; van der Werf, TS; Velink, A; Woolley, RJ	1
Fernandez, RS; Tanywe, A	1
Afari, EA; Anim, J; Antara, SN; Iddrisah, FN; Kenu, E; Nortey, PA; Nyarko, KM; Wurapa, F; Yeboah-Manu, D	1
Anyo, G; Fraga, AG; Kibadi, K; Longatto Filho, A; Meyers, WM; Nakazawa, Y; Panda, M; Pedrosa, J; Portaels, F; Suykerbuyk, P; Tamfum, JJ	1
Adentwe, E; Ampadu, E; Phillips, RO; Sarfo, FS; Sarpong, F; Wansbrough-Jones, M	1
Pluschke, G; Schütte, D; Umboock, A	1
Aubry, A; Chauffour, A; Ibrahim, M; Jarlier, V; Ji, B; Robert, J	1
Hauck, FR; Houp, E; Portaels, F; Webb, BJ	1
Abass, KM; Adjei, O; Ampadu, EO; Awua-Boateng, NY; Awuah, PC; Bretzel, G; Nienhuis, WA; Schouten, JP; Siegmund, V; Stienstra, Y; Thompson, WA; Tuah, W; van der Werf, TS	1
Colebunders, R; Kibadi, K; Meyers, WM; Muyembe-Tamfum, JJ; Portaels, F	1
Billal, DS	1
Adentwe, E; Ampadu, E; Asiedu, K; Bobi, N; Lartey, A; Phillips, R; Sarfo, FS; Tetteh, I; Wansbrough-Jones, M	1
Boelaert, M; Fraga, AG; Kayinua, M; Kibadi, K; Longatto-Filho, A; Meyers, WM; Minuku, JB; Mputu-Yamba, JB; Muyembe-Tamfum, JJ; Pedrosa, J; Portaels, F; Roux, JJ	1
Affolabi, D; Anagonou, SY; Barogui, YT; Brun, LV; Dossou, AD; Houézo, JG; Johnson, RC; Kestens, L; Portaels, F; Sopoh, GE	1
Milánkovits, M	1
Adeye, A; Ardant, MF; Chauty, A; Johnson, RC; Koussemou, H; Pluschke, G; Ruf, MT	1
Barogui, YT; Brun, LV; Dossou, AD; Johnson, RC; Pluschke, G; Ruf, MT; Sopoh, GE	1
Almeida, DV; Converse, PJ; Grosset, JH; Nuermberger, EL	1
Ampadu, ED; Asan-Ampah, K; Asante-Poku, A; Pluschke, G; Yeboah-Manu, D	1
Chauffour, A; Jarlier, V; Ji, B; Pluschke, G; Ruf, MT; Schütte, D	1
Castro, AG; Fraga, AG; Gama, JB; Martins, TG; Pedrosa, J; Saraiva, M; Silva, MT	1
Yotsu, R	1
Amekuse, K; Badziklou, K; Banla Kere, A; Beissner, M; Bretzel, G; Diefenhardt, A; Hoffmann, H; Jansson, M; Kobara, B; Löscher, T; Maman, I; Nitschke, J; Piten, E; Symank, D; Wiedemann, F	1
Dehn, TC; Tsukagoshi, S	1
Castro, AG; Fraga, AG; Gama, JB; Longatto-Filho, A; Martins, TG; Pedrosa, J; Saraiva, M; Silva, MT; Trigo, G	1
Adeye, A; Ardant, MF; Aubry, J; Chauty, A; Euverte, H; Grosset, J; Guédénon, A; Johnson, C; Nuermberger, E	1
Itin, P; Mensah-Quainoo, E; Pluschke, G; Schmid, P; Schütte, D; Um-Boock, A	1

Reviews

5 review(s) available for streptomycin and Buruli Ulcer Disease

Article	Year
Buruli Ulcer: Review of a Neglected Skin Mycobacterial Disease. Journal of clinical microbiology, 2018, Volume: 56, Issue:4 Topics: Africa, Western; Anti-Bacterial Agents; Buruli Ulcer; Clarithromycin; Humans; Macrolides; Mycobacterium Infections; Mycobacterium ulcerans; Neglected Diseases; Polymerase Chain Reaction; Rifampin; Skin Diseases, Bacterial; Streptomycin	2018
Drugs for treating Buruli ulcer (Mycobacterium ulcerans disease). The Cochrane database of systematic reviews, 2018, 08-23, Volume: 8 Topics: Anti-Bacterial Agents; Buruli Ulcer; Clarithromycin; Clofazimine; Drug Therapy, Combination; Humans; Mycobacterium ulcerans; Observational Studies as Topic; Randomized Controlled Trials as Topic; Rifampin; Streptomycin; Trimethoprim, Sulfamethoxazole Drug Combination	2018
Effectiveness of rifampicin-streptomycin for treatment of Buruli ulcer: a systematic review. JBI database of systematic reviews and implementation reports, 2017, Volume: 15, Issue:1 Topics: Administration, Oral; Anti-Bacterial Agents; Buruli Ulcer; Drug Administration Schedule; Drug Therapy, Combination; Humans; Mycobacterium ulcerans; Rifampin; Streptomycin; Treatment Outcome	2017
Buruli ulcer in West Africa: strategies for early detection and treatment in the antibiotic era. East African journal of public health, 2009, Volume: 6, Issue:2 Topics: Africa, Western; Anti-Bacterial Agents; Buruli Ulcer; Drug Therapy, Combination; Early Diagnosis; Humans; Mycobacterium ulcerans; Rifampin; Streptomycin; Treatment Outcome	2009
Treating Mycobacterium ulcerans disease (Buruli ulcer): from surgery to antibiotics, is the pill mightier than the knife? Future microbiology, 2011, Volume: 6, Issue:10 Topics: Adolescent; Animals; Anti-Bacterial Agents; Buruli Ulcer; Clinical Trials as Topic; Disease Models, Animal; Drug Therapy, Combination; Female; Humans; Mice; Mycobacterium ulcerans; Rifampin; Streptomycin; Treatment Outcome; Young Adult	2011

Trials

5 trial(s) available for streptomycin and Buruli Ulcer Disease

Article	Year
Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial. Lancet (London, England), 2020, 04-18, Volume: 395, Issue:10232 Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Benin; Buruli Ulcer; Child; Clarithromycin; Delayed-Action Preparations; Drug Therapy, Combination; Female; Ghana; Humans; Male; Rifampin; Streptomycin; Wound Healing; Young Adult	2020
Long term streptomycin toxicity in the treatment of Buruli Ulcer: follow-up of participants in the BURULICO drug trial. PLoS neglected tropical diseases, 2014, Volume: 8, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Audiometry; Buruli Ulcer; Child; Child, Preschool; Creatinine; Drug-Related Side Effects and Adverse Reactions; Female; Hearing Loss; Humans; Kidney Diseases; Male; Middle Aged; Streptomycin; Young Adult	2014
Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial. Lancet (London, England), 2010, Feb-20, Volume: 375, Issue:9715 Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Buruli Ulcer; Child; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Endpoint Determination; Female; Follow-Up Studies; Ghana; Humans; Injections, Intramuscular; Leprostatic Agents; Male; Mycobacterium ulcerans; Rifampin; Statistics, Nonparametric; Streptomycin; Time Factors; Treatment Outcome; Young Adult	2010
Clinical efficacy of combination of rifampin and streptomycin for treatment of Mycobacterium ulcerans disease. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:9 Topics: Adolescent; Adult; Aged; Buruli Ulcer; Child; Child, Preschool; Drug Combinations; Female; Humans; Infant; Male; Middle Aged; Mycobacterium ulcerans; Rifampin; Streptomycin; Treatment Outcome; Young Adult	2010
Promising clinical efficacy of streptomycin-rifampin combination for treatment of buruli ulcer (Mycobacterium ulcerans disease). Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:11 Topics: Adolescent; Adult; Anti-Bacterial Agents; Buruli Ulcer; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Mycobacterium ulcerans; Rifampin; Streptomycin; Survival Analysis; Treatment Outcome	2007

Other Studies

42 other study(ies) available for streptomycin and Buruli Ulcer Disease

Article	Year
Using bioluminescence to monitor treatment response in real time in mice with Mycobacterium ulcerans infection. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:1 Topics: Animals; Anti-Bacterial Agents; Buruli Ulcer; Female; Kanamycin; Luminescence; Mice; Mice, Inbred BALB C; Mycobacterium ulcerans; Rifampin; Streptomycin	2011
Development of an antibiotics delivery system for topical treatment of the neglected tropical disease Buruli ulcer. International journal of pharmaceutics, 2022, Jul-25, Volume: 623 Topics: Anti-Bacterial Agents; Buruli Ulcer; Humans; Hydrogels; Polyesters; Quality of Life; Rifampin; Streptomycin	2022
Child case of Buruli ulcer successfully treated through a school-based skin survey project in Côte d'Ivoire. The Journal of dermatology, 2020, Volume: 47, Issue:2 Topics: Antibiotics, Antitubercular; Arm; Buruli Ulcer; Child; Cote d'Ivoire; Drug Therapy, Combination; Humans; Male; Mass Screening; Mycobacterium ulcerans; Neglected Diseases; Rifampin; School Health Services; Skin; Streptomycin; Treatment Outcome	2020
Buruli ulcer: cured by 8 weeks of oral antibiotics? Lancet (London, England), 2020, 04-18, Volume: 395, Issue:10232 Topics: Anti-Bacterial Agents; Buruli Ulcer; Clarithromycin; Humans; Rifampin; Streptomycin	2020
Microbiology of secondary infections in Buruli ulcer lesions; implications for therapeutic interventions. BMC microbiology, 2021, 01-05, Volume: 21, Issue:1 Topics: Adult; Amikacin; Anti-Bacterial Agents; Bacillus; Bacteria; Buruli Ulcer; Candida; Clarithromycin; Coinfection; Cote d'Ivoire; Cross-Sectional Studies; Female; Fungi; Ghana; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillium; Staphylococcus; Streptomycin; Trichoderma; Watchful Waiting; Young Adult	2021
Implementation of a decentralized community-based treatment program to improve the management of Buruli ulcer in the Ouinhi district of Benin, West Africa. PLoS neglected tropical diseases, 2018, Volume: 12, Issue:3 Topics: Anti-Bacterial Agents; Benin; Buruli Ulcer; Community Health Services; Disease Management; Early Medical Intervention; Female; Health Impact Assessment; Health Plan Implementation; Humans; Male; Mycobacterium ulcerans; Rifampin; Streptomycin	2018
Shortening Buruli Ulcer Treatment with Combination Therapy Targeting the Respiratory Chain and Exploiting Mycobacterium ulcerans Gene Decay. Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:7 Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Buruli Ulcer; Clarithromycin; Clofazimine; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Electron Transport; Humans; Imidazoles; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium ulcerans; Piperidines; Pyridines; Rifampin; Streptomycin	2019
Bactericidal activity does not predict sterilizing activity: the case of rifapentine in the murine model of Mycobacterium ulcerans disease. PLoS neglected tropical diseases, 2013, Volume: 7, Issue:2 Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Buruli Ulcer; Colony Count, Microbial; Disease Models, Animal; Drug Therapy, Combination; Female; Mice; Mice, Inbred BALB C; Microbial Viability; Mycobacterium ulcerans; Rifampin; Secondary Prevention; Streptomycin; Treatment Outcome	2013
Microbiological, histological, immunological, and toxin response to antibiotic treatment in the mouse model of Mycobacterium ulcerans disease. PLoS neglected tropical diseases, 2013, Volume: 7, Issue:3 Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Buruli Ulcer; Cell Survival; Disease Models, Animal; Histocytochemistry; Macrolides; Mass Spectrometry; Mice; Mice, Inbred BALB C; Mycobacterium ulcerans; Rifampin; Streptomycin	2013
Secondary bacterial infections of buruli ulcer lesions before and after chemotherapy with streptomycin and rifampicin. PLoS neglected tropical diseases, 2013, Volume: 7, Issue:5 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteria; Buruli Ulcer; Child; Child, Preschool; Coinfection; Drug Resistance, Bacterial; Female; Ghana; Humans; Male; Middle Aged; Rifampin; Streptomycin; Wound Infection; Young Adult	2013
Clinical and bacteriological efficacy of rifampin-streptomycin combination for two weeks followed by rifampin and clarithromycin for six weeks for treatment of Mycobacterium ulcerans disease. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:2 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Buruli Ulcer; Child; Child, Preschool; Clarithromycin; Drug Synergism; Drug Therapy, Combination; Female; Ghana; Humans; Middle Aged; Mycobacterium ulcerans; Rifampin; Skin; Streptomycin; Treatment Outcome	2014
Treatment and prevention of Mycobacterium ulcerans infection (Buruli ulcer) in Australia: guideline update. The Medical journal of Australia, 2014, Mar-17, Volume: 200, Issue:5 Topics: Anti-Bacterial Agents; Australia; Buruli Ulcer; Debridement; Drug Therapy, Combination; Hot Temperature; Humans; Mycobacterium ulcerans; Practice Guidelines as Topic; Rifampin; Streptomycin	2014
Buruli ulcer disease in Republic of the Congo. Emerging infectious diseases, 2014, Volume: 20, Issue:6 Topics: Adolescent; Adult; Anti-Bacterial Agents; Buruli Ulcer; Child; Child, Preschool; Congo; Epidemiological Monitoring; Female; Humans; Male; Mycobacterium ulcerans; Neglected Diseases; Rifampin; Streptomycin	2014
Compliance with antimicrobial therapy for buruli ulcer. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:10 Topics: Anti-Bacterial Agents; Buruli Ulcer; Clarithromycin; Female; Humans; Mycobacterium ulcerans; Rifampin; Streptomycin	2014
Reply to "compliance with antimicrobial therapy for buruli ulcer". Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:10 Topics: Anti-Bacterial Agents; Buruli Ulcer; Clarithromycin; Female; Humans; Mycobacterium ulcerans; Rifampin; Streptomycin	2014
In-vitro activity of avermectins against Mycobacterium ulcerans. PLoS neglected tropical diseases, 2015, Volume: 9, Issue:3 Topics: Administration, Oral; Buruli Ulcer; Ivermectin; Microbial Sensitivity Tests; Mycobacterium ulcerans; Rifampin; Streptomycin	2015
Efficacy of Rifampin Plus Clofazimine in a Murine Model of Mycobacterium ulcerans Disease. PLoS neglected tropical diseases, 2015, Volume: 9, Issue:6 Topics: Animals; Buruli Ulcer; Clarithromycin; Clofazimine; Colony Count, Microbial; Drug Evaluation, Preclinical; Drug Therapy, Combination; Foot; Macrolides; Mice; Microbial Sensitivity Tests; Rifampin; Streptomycin; Survival Analysis; Time Factors; Treatment Outcome	2015
Challenges Associated with Management of Buruli Ulcer/Human Immunodeficiency Virus Coinfection in a Treatment Center in Ghana: A Case Series Study. The American journal of tropical medicine and hygiene, 2015, Volume: 93, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antiretroviral Therapy, Highly Active; Buruli Ulcer; Child; Child, Preschool; Coinfection; Disease Management; Female; Ghana; HIV Infections; Humans; Male; Middle Aged; Mycobacterium ulcerans; Rifampin; Streptomycin; World Health Organization; Young Adult	2015
Mycobacterium ulcerans disease in the middle belt of Ghana: An eight-year review from six endemic districts. International journal of mycobacteriology, 2015, Volume: 4, Issue:2 Topics: Adolescent; Adult; Anti-Bacterial Agents; Buruli Ulcer; Child; Endemic Diseases; Female; Ghana; Humans; Male; Mycobacterium ulcerans; Rifampin; Streptomycin; Young Adult	2015
Clinical outcomes of Ghanaian Buruli ulcer patients who defaulted from antimicrobial therapy. Tropical medicine & international health : TM & IH, 2016, Volume: 21, Issue:9 Topics: Adolescent; Adult; Anti-Bacterial Agents; Buruli Ulcer; Cohort Studies; Drug Administration Schedule; Drug Therapy, Combination; Female; Ghana; Hospitals; Humans; Male; Medication Adherence; Middle Aged; Mycobacterium ulcerans; Rifampin; Streptomycin; Treatment Outcome; Wound Healing; Young Adult	2016
Former Buruli Ulcer Patients' Experiences and Wishes May Serve as a Guide to Further Improve Buruli Ulcer Management. PLoS neglected tropical diseases, 2016, Volume: 10, Issue:12 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Buruli Ulcer; Female; Focus Groups; Ghana; Humans; Interviews as Topic; Male; Middle Aged; Mycobacterium ulcerans; Patient Preference; Rifampin; Streptomycin; Surveys and Questionnaires; Treatment Outcome; Young Adult	2016
Outcome of Streptomycin-Rifampicin treatment of Buruli Ulcer in two Ghanaian districts. The Pan African medical journal, 2016, Volume: 25, Issue:Suppl 1 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Buruli Ulcer; Child; Drug Therapy, Combination; Female; Follow-Up Studies; Ghana; Humans; Longitudinal Studies; Male; Middle Aged; Mycobacterium ulcerans; Rifampin; Streptomycin; Time Factors; Treatment Outcome; Wound Healing; Young Adult	2016
New foci of Buruli ulcer, Angola and Democratic Republic of Congo. Emerging infectious diseases, 2008, Volume: 14, Issue:11 Topics: Adolescent; Adult; Angola; Antibiotics, Antitubercular; Biopsy; Buruli Ulcer; Democratic Republic of the Congo; Diamond; Disease Reservoirs; Female; Humans; Male; Mining; Mycobacterium ulcerans; Rifampin; Risk Factors; Rivers; Skin; Streptomycin; Treatment Outcome	2008
Dynamics of the cytokine response to Mycobacterium ulcerans during antibiotic treatment for M. ulcerans disease (Buruli ulcer) in humans. Clinical and vaccine immunology : CVI, 2009, Volume: 16, Issue:1 Topics: Adolescent; Adult; Anti-Bacterial Agents; Buruli Ulcer; Child; Female; Humans; Interferon-gamma; Interleukin-10; Male; Middle Aged; Mycobacterium ulcerans; Rifampin; Streptomycin	2009
Phagocytosis of Mycobacterium ulcerans in the course of rifampicin and streptomycin chemotherapy in Buruli ulcer lesions. The British journal of dermatology, 2009, Volume: 160, Issue:2 Topics: Adolescent; Anti-Bacterial Agents; Buruli Ulcer; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Child; Drug Therapy, Combination; Female; Granuloma; Humans; Macrophages; Male; Middle Aged; Phagocytosis; Rifampin; Streptomycin; Treatment Outcome	2009
Impacts of dosing frequency of the combination rifampin-streptomycin on its bactericidal and sterilizing activities against Mycobacterium ulcerans in mice. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:7 Topics: Animals; Anti-Bacterial Agents; Buruli Ulcer; Drug Therapy, Combination; Female; Mice; Mice, Inbred BALB C; Mycobacterium ulcerans; Rifampin; Streptomycin; Treatment Outcome	2009
Buruli ulcer lesions in HIV-positive patient. Emerging infectious diseases, 2010, Volume: 16, Issue:4 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antibiotics, Antitubercular; Buruli Ulcer; Drug Therapy, Combination; Humans; Male; Rifampin; Streptomycin	2010
Antimicrobial drugs for Buruli ulcer. Lancet (London, England), 2010, May-29, Volume: 375, Issue:9729 Topics: Animals; Anti-Bacterial Agents; Buruli Ulcer; Clarithromycin; Drug Therapy, Combination; Ghana; Humans; Mice; Rifampin; Streptomycin	2010
Response to treatment in a prospective cohort of patients with large ulcerated lesions suspected to be Buruli Ulcer (Mycobacterium ulcerans disease). PLoS neglected tropical diseases, 2010, Jul-06, Volume: 4, Issue:7 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteriological Techniques; Buruli Ulcer; Child; Child, Preschool; Cohort Studies; Democratic Republic of the Congo; Female; Histocytochemistry; Humans; Male; Middle Aged; Mycobacterium ulcerans; Prospective Studies; Rifampin; Streptomycin; Treatment Outcome; Young Adult	2010
Severe multifocal form of buruli ulcer after streptomycin and rifampin treatment: comments on possible dissemination mechanisms. The American journal of tropical medicine and hygiene, 2010, Volume: 83, Issue:2 Topics: Anti-Bacterial Agents; Buruli Ulcer; Child; Humans; Male; Osteomyelitis; Rifampin; Streptomycin	2010
[Combined local and vaginal therapy in Buruli ulcer]. Orvosi hetilap, 2010, Aug-29, Volume: 151, Issue:35 Topics: Adolescent; Age Distribution; Aged; AIDS-Related Opportunistic Infections; Amikacin; Anti-Infective Agents; Buruli Ulcer; Child; Combined Modality Therapy; Debridement; Drug Therapy, Combination; Female; Humans; Metronidazole; Mycobacterium ulcerans; Osteomyelitis; Rifampin; Streptomycin	2010
Buruli ulcer. A disabling infection. Prescrire international, 2010, Volume: 19, Issue:110 Topics: Antitubercular Agents; Buruli Ulcer; Drug Therapy, Combination; Humans; Rifampin; Streptomycin; Water Microbiology	2010
Secondary Buruli ulcer skin lesions emerging several months after completion of chemotherapy: paradoxical reaction or evidence for immune protection? PLoS neglected tropical diseases, 2011, Volume: 5, Issue:8 Topics: Antibiotics, Antitubercular; Antigens, CD; Buruli Ulcer; Child; Humans; Immunohistochemistry; Leukocytes; Male; Mycobacterium ulcerans; Necrosis; Neglected Diseases; Rifampin; Skin; Streptomycin; Treatment Outcome	2011
Histopathological changes and clinical responses of Buruli ulcer plaque lesions during chemotherapy: a role for surgical removal of necrotic tissue? PLoS neglected tropical diseases, 2011, Volume: 5, Issue:9 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Benin; Biopsy; Buruli Ulcer; Child; Child, Preschool; Debridement; Drug Therapy; Female; Histocytochemistry; Humans; Immunohistochemistry; Male; Microscopy; Middle Aged; Mycobacterium ulcerans; Rifampin; Skin; Streptomycin; Treatment Outcome; Young Adult	2011
Combining PCR with microscopy to reduce costs of laboratory diagnosis of Buruli ulcer. The American journal of tropical medicine and hygiene, 2011, Volume: 85, Issue:5 Topics: Anti-Bacterial Agents; Biopsy, Fine-Needle; Buruli Ulcer; Ghana; Health Care Costs; Humans; Microscopy; Mycobacterium ulcerans; Polymerase Chain Reaction; Rifampin; Sensitivity and Specificity; Streptomycin	2011
Chemotherapy-associated changes of histopathological features of Mycobacterium ulcerans lesions in a Buruli ulcer mouse model. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:2 Topics: Animals; Anti-Bacterial Agents; Buruli Ulcer; Colony Count, Microbial; Disease Models, Animal; Drug Therapy, Combination; Female; Foot; Humans; Mice; Mice, Inbred BALB C; Mycobacterium ulcerans; Rifampin; Streptomycin; Treatment Outcome	2012
Local and regional re-establishment of cellular immunity during curative antibiotherapy of murine Mycobacterium ulcerans infection. PloS one, 2012, Volume: 7, Issue:2 Topics: Animals; Anti-Bacterial Agents; Buruli Ulcer; Dexamethasone; Disease Models, Animal; Disease Progression; Drug Therapy, Combination; Female; Flow Cytometry; Immunity, Cellular; Immunosuppressive Agents; Inflammation; Lymphocytes; Mice; Mice, Inbred BALB C; Mycobacterium ulcerans; Rifampin; Streptomycin	2012
[Ghana: the experience in the land highly endemic for Buruli ulcer]. Nihon Hansenbyo Gakkai zasshi = Japanese journal of leprosy : official organ of the Japanese Leprosy Association, 2012, Volume: 81, Issue:1-2 Topics: Buruli Ulcer; Communicable Disease Control; Drug Therapy, Combination; Early Diagnosis; Ghana; Humans; National Health Programs; Rifampin; Streptomycin; World Health Organization	2012
Spontaneous clearance of a secondary Buruli ulcer lesion emerging ten months after completion of chemotherapy--a case report from Togo. PLoS neglected tropical diseases, 2012, Volume: 6, Issue:7 Topics: Anti-Bacterial Agents; Buruli Ulcer; Child; DNA Transposable Elements; DNA, Bacterial; Humans; Male; Mycobacterium ulcerans; Polymerase Chain Reaction; Streptomycin; Togo	2012
Buruli ulcer in a nine-month-old boy. Annals of the Royal College of Surgeons of England, 2012, Volume: 94, Issue:7 Topics: Antitubercular Agents; Buruli Ulcer; Forearm; Humans; Infant; Male; Rifampin; Streptomycin	2012
Corticosteroid-induced immunosuppression ultimately does not compromise the efficacy of antibiotherapy in murine Mycobacterium ulcerans infection. PLoS neglected tropical diseases, 2012, Volume: 6, Issue:11 Topics: Adrenal Cortex Hormones; Animals; Anti-Bacterial Agents; Buruli Ulcer; Disease Models, Animal; Female; Foot; Histocytochemistry; Immunohistochemistry; Immunosuppressive Agents; Mice; Mice, Inbred BALB C; Mycobacterium ulcerans; Rifampin; Streptomycin; Treatment Outcome	2012
Development of highly organized lymphoid structures in Buruli ulcer lesions after treatment with rifampicin and streptomycin. PLoS neglected tropical diseases, 2007, Oct-31, Volume: 1, Issue:1 Topics: Anti-Bacterial Agents; Buruli Ulcer; Child; Ghana; Granuloma; Humans; Immunohistochemistry; Lymphocytes; Mycobacterium; Mycobacterium Infections; Rifampin; Streptomycin	2007